Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 4 studies | 31% ± 14% |
Insufficient scRNA-seq data for expression of CLCA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 39% | 7467.32 | 559 / 1445 | 61% | 246.25 | 111 / 183 |
tonsil | 0% | 0 | 0 / 0 | 84% | 246.19 | 38 / 45 |
skin | 73% | 5780.58 | 1329 / 1809 | 9% | 9.23 | 44 / 472 |
uterus | 2% | 158.59 | 3 / 170 | 54% | 160.74 | 250 / 459 |
bladder | 14% | 593.24 | 3 / 21 | 34% | 73.88 | 172 / 504 |
lung | 3% | 32.59 | 19 / 578 | 37% | 104.38 | 422 / 1155 |
breast | 14% | 292.61 | 66 / 459 | 19% | 25.26 | 209 / 1118 |
prostate | 17% | 401.92 | 42 / 245 | 2% | 0.54 | 8 / 502 |
pancreas | 0% | 0 | 0 / 328 | 7% | 6.26 | 12 / 178 |
thymus | 0% | 0.82 | 1 / 653 | 4% | 2.25 | 24 / 605 |
intestine | 0% | 1.70 | 2 / 966 | 4% | 5.56 | 20 / 527 |
adipose | 1% | 23.05 | 18 / 1204 | 0% | 0 | 0 / 0 |
stomach | 1% | 17.26 | 2 / 359 | 0% | 0.47 | 1 / 286 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.46 | 1 / 230 |
brain | 0% | 0.64 | 3 / 2642 | 0% | 0.20 | 2 / 705 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.73 | 3 / 901 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.08 | 1 / 430 |
blood vessel | 0% | 4.41 | 2 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.93 | 1 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.53 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0007155 | Biological process | cell adhesion |
GO_0006508 | Biological process | proteolysis |
GO_0030054 | Cellular component | cell junction |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0070161 | Cellular component | anchoring junction |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005254 | Molecular function | chloride channel activity |
GO_0005229 | Molecular function | intracellularly calcium-gated chloride channel activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CLCA2 |
Protein name | Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form] |
Synonyms | CACC3 |
Description | FUNCTION: Plays a role in modulating chloride current across the plasma membrane in a calcium-dependent manner, and cell adhesion. Involved in basal cell adhesion and/or stratification of squamous epithelia. May act as a tumor suppressor in breast and colorectal cancer. Plays a key role for cell adhesion in the beginning stages of lung metastasis via the binding to ITGB4. . |
Accessions | ENST00000370565.5 Q9UQC9 |